Latest Breaking News On - Trials show slowing - Page 1 : comparemela.com

The FDA has approved Izervay, a new drug that slows the progression of geographic atrophy, an advanced stage of age-related macular degeneration (AMD).

New jerseyUnited statesJeff toddIveric bioPetera campochiaroIveric simmsChris simmsApellis pharmaceuticalsDrug administrationDrugs help fillSignificant treatmentPrevent blindnessTrials show slowingEffects areDolores dorEccles professor